New Zealand markets closed

Biophytis S.A. (BPTS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2901-0.0249 (-7.90%)
At close: 04:00PM EDT
0.2855 -0.00 (-1.59%)
After hours: 06:23PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3150
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.2811 - 0.3000
52-week range0.2660 - 4.2200
Avg. volume341,350
Market cap3.325M
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up

    Biophytis (BPTS) rises in the after-market hours as it announces the launch of a new clinical development program for its investigational candidate, BIO101, to treat obesity in combination with GLP-1 drugs.

  • Insider Monkey

    40 Cities with the Lowest Life Expectancy in the US

    In this article, we look at 40 cities with the lowest life expectancy in the US. You can skip our section on developments in the pharmaceutical and biotech industries to enhance longevity and head over directly to 10 Cities with the Lowest Life Expectancy in the US. Average lifespan in the US climbed from just […]

  • Zacks

    Biophytis (BPTS) Soars 73% on Partnership With Skyepharma

    Biophytis (BPTS) gains on signing a partnership with Skyepharma, for the production of regulatory batches of its lead candidate, Sarconeos (BIO101).